Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$44,342,057
+$11,397,534 QoQ
Shares Held
1,785,107
+37.7% QoQ
Ownership
0.869%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 98%
Shared 0%
None 1%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. IMVT ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in IMVT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,342,057 | 1,785,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,944,523 | 1,296,008 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $23,898,528 | 1,482,539 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,128,256 | 1,195,516 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,221,592 | 1,007,700 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $16,802,629 | 678,346 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $14,872,896 | 521,673 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,874,634 | 411,918 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,281,907 | 349,177 | Shares | Defined | 2024-05-15 | |
| 2022-03-31 | $1,959,873 | 355,694 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,503,592 | 293,849 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $3,988,475 | 458,973 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,174,607 | 205,734 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,783,950 | 1,046,381 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $36,340,212 | 786,755 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,338,962 | 123,301 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,665,575 | 150,537 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,149,350 | 73,842 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||